Factors associated with viral rebound among COVID-19 patients receiving oral antivirals-Reference-Cited by-全球学者库

Factors associated with viral rebound among COVID-19 patients receiving oral antivirals

Published:2023-08 Issue:8 Volume:122 Page:766-775
ISSN:0929-6646
Container-title:Journal of the Formosan Medical Association
language:en
Short-container-title:Journal of the Formosan Medical Association

Author:

Chen Pao-Yu,Wang Jann-Tay^ORCID,Chang Sui-Yuan,Hung Chien-Ching,Fang Chi-Tai^ORCID,Cheng Aristine,Liu Wang-Da,Huang Yu-Shan,Lin Kuan-Yin,Sun Hsin-Yun^ORCID,Pan Sung-Ching,Cheng Yu-Cheng,Wang Hurng-Yi,Sheng Wang-Huei,Chen Yee-Chun,Ho Yi-Lwun,Wu Ming-Shiang,Chang Shan-Chwen^ORCID

Funder

National Taiwan University Hospital

Ministry of Health and Welfare

Ministry of Science and Technology, Taiwan

Publisher

Elsevier BV

Subject

General Medicine

Reference32 articles.

1. Oral nirmatrelvir for high-risk, nonhospitalized adults with covid-19;Hammond;N Engl J Med,2022

2. Molnupiravir for oral treatment of covid-19 in nonhospitalized patients;Jayk Bernal;N Engl J Med,2022

3. Guidelines for clinical management of SARS-CoV-2 infection, Taiwan centers for disease control [Tranditinal Chinese version]. Available at https://www.cdc.gov.tw/Category/Page/xCSwc5oznwcqunujPc-qmQ [Accessed January 31, 2023].

4. COVID-19 Treatment Guidelines Panel. Coronavirus disease 2019 (COVID-19) treatment guidelines. National Institutes of Health. Available at https://www.covid19treatmentguidelines.nih.gov/. [Accessed December 8, 2022].

5. Update to living WHO guideline on drugs for covid-19;BMJ,2022

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. SARS-CoV-2 Rebound With and Without Use of COVID-19 Oral Antivirals;MMWR. Morbidity and Mortality Weekly Report;2023-12-22

2. Highlights;Journal of the Formosan Medical Association;2023-08